NUBEQA is currently indicated for the treatment of adult patients with mHSPC in combination with docetaxel and for non-metastatic castration-resistant prostate cancer (nmCRPC)
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
The company will also share results in two additional posters for deuruxolitinib
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Quinidine Sulphate helps manage rare irregular heartbeat conditions
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Subscribe To Our Newsletter & Stay Updated
